Literature DB >> 2058467

Influence of no-donor (SIN-1) on functions of inflammatory cells.

A Dembińska-Kieć1, A Zmuda, J Marcinkiewicz, H Sinzinger, R J Gryglewski.   

Abstract

NO-donor SIN-1 (0.01-1.0 mM) dose-dependently inhibited the basal and FMLP (30.0 mM)-stimulated release of beta-glucuronidase from rat peritoneal leukocytes and antigen-specific stimulation of Interleukin-2 production by T-hybridomas. I-123 LDL binding to human lymphocytes was inhibited by Iloprost (1 mM) but activated by SIN-1 (0.3 mM). We conclude that beside the smooth muscle cells and platelets the blood inflammatory/immune cells are under the PGI2/NO control, however, the precise regulation as well as physiological importance need further investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058467     DOI: 10.1007/bf01983305

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  17 in total

1.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Cytoprotection of human polymorphonuclear leukocytes by stimulators of adenylate and guanylate cyclases.

Authors:  R Korbut; E Trabka-Janik; R J Gryglewski
Journal:  Eur J Pharmacol       Date:  1989-06-08       Impact factor: 4.432

3.  Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation.

Authors:  T Nakayasu; M Macy; Y Okano; B M McCarthy; J A Harmony
Journal:  Exp Cell Res       Date:  1986-03       Impact factor: 3.905

4.  Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.

Authors:  D Salvemini; G de Nucci; R J Gryglewski; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

6.  Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.

Authors:  R M Palmer; R J Stepney; G A Higgs; K E Eakins
Journal:  Prostaglandins       Date:  1980-08

7.  Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.

Authors:  K Schrör; R Ohlendorf; H Darius
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

8.  An improved colorimetric assay for interleukin 2.

Authors:  H Tada; O Shiho; K Kuroshima; M Koyama; K Tsukamoto
Journal:  J Immunol Methods       Date:  1986-11-06       Impact factor: 2.303

9.  Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron.

Authors:  M Feelisch; E Noack
Journal:  Eur J Pharmacol       Date:  1987-10-27       Impact factor: 4.432

10.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  1 in total

1.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.